Average Co-Inventor Count = 7.00
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mitsubishi Chemical Industries Limited (41 from 614 patents)
2. Other (35 from 832,880 patents)
3. Shosuke Okamoto (3 from 5 patents)
41 patents:
1. 4258192 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically
2. 4201863 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically
3. 4173630 - N.sup.2 Arylsulfonyl-L-argininamides and the pharmaceutically acceptable
4. 4140681 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically
5. 4139529 - N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives and the
6. 4133880 - N.sup.2 -Substituted-L-arginine derivatives and the pharmaceutically
7. 4131673 - N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically
8. 4125619 - N.sup.2 -naphthalenesulfonyl-L-arginine derivatives and the
9. 4125604 - N2-Arylsulfonyl-L-argininamides and the pharmaceutically acceptable
10. 4117127 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically
11. 4108986 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically
12. 4104392 - N.sup.2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically
13. 4101653 - N.sup.2 -arylsulfonyl-argininamides and the pharmaceutically acceptable
14. 4097591 - N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically
15. 4097472 - N.sup.2 -arylsulfonyl-l-argininamides and the pharmaceutically